Respicardia

Developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.

Launch date

2006

Employees

Market cap

Enterprise valuation

Minnetonka Minnesota (HQ)

Date	Investors	Amount	Round
Dec 2006	Affinity Capital Management Accuitive Medical Ventures Three Arch Partners	$5.5m	Series A
Oct 2008	Polaris Partners Affinity Capital Management Accuitive Medical Ventures Three Arch Partners Versant Ventures RK Ventures Group	$21.0m	Series B
Aug 2010	Polaris Partners Affinity Capital Management Accuitive Medical Ventures Three Arch Partners Versant Ventures Abbott	$27.0m	Series C
Sep 2013	Affinity Capital Management	$10.0m	Series D
Jul 2014	N/A	$2.0m	Convertible
Oct 2014	N/A	$20.0m	Late VC
Jul 2017	Sorin Group	$5.1m	Debt
Dec 2017	Polaris Partners Sorin Group Versant Ventures ZOLL Medical Corporation	$58.5m	Late VC
Apr 2021	ZOLL Medical Corporation	N/A	Acquisition
Total Funding		$144m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Respicardia